{"disease":{"id":"nmosd","name":"nmosd"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT07032337","title":"Efficacy and Safety of Conventional Immunosuppressant Therapies in Elderly Patients With Neuromyelitis Optica Spectrum Disorder","phase":"","overall_status":"COMPLETED","enrollment_count":2985,"lead_sponsor_name":"Samsung Medical Center","has_results":false},{"nct_id":"NCT07420296","title":"Modified Zipper Therapy for AQP4-IgG Positive Neuromyelitis Optica Spectrum Disorder","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":198,"lead_sponsor_name":"Tianjin Medical University General Hospital","has_results":false},{"nct_id":"NCT07132398","title":"Slow vs. Rapid Glucocorticoids Tapering With Inebilizumab in NMOSD","phase":"PHASE3","overall_status":"NOT_YET_RECRUITING","enrollment_count":170,"lead_sponsor_name":"Tianjin Medical University General Hospital","has_results":false},{"nct_id":"NCT07087873","title":"Assessment of Transcranial Alternating Current Stimulation's Clinical Efficacy in Treating Cognitive Impairment of Idiopathic Inflammatory Demyelinating Diseases","phase":"NA","overall_status":"RECRUITING","enrollment_count":128,"lead_sponsor_name":"Xuanwu Hospital, Beijing","has_results":false},{"nct_id":"NCT05966467","title":"Registry of Patients With AQP4+ NMOSD Treated With Alexion C5 Inhibitor Therapies","phase":"","overall_status":"RECRUITING","enrollment_count":122,"lead_sponsor_name":"Alexion Pharmaceuticals, Inc.","has_results":false},{"nct_id":"NCT06767020","title":"Comparative Study on AQP4 Antibody Detection Methods","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":120,"lead_sponsor_name":"First Affiliated Hospital of Chongqing Medical University","has_results":false},{"nct_id":"NCT06557174","title":"A Study to Evaluate IMC-002 in Neuromyelitis Optica Spectrum Disorder (NMOSD) Patients","phase":"PHASE1, PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":116,"lead_sponsor_name":"ImmuneCare Biopharmaceuticals (Shanghai) Co., Ltd.","has_results":false},{"nct_id":"NCT06829524","title":"HANDLE-a Real World Study on Satralizumab in NMOSD","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":100,"lead_sponsor_name":"Huashan Hospital","has_results":false},{"nct_id":"NCT07247292","title":"Epidemiological Study of Treatment Approaches on AQP4-IgG Positive NMOSD in Russia","phase":"","overall_status":"SUSPENDED","enrollment_count":100,"lead_sponsor_name":"AstraZeneca","has_results":false},{"nct_id":"NCT07304960","title":"Multiple Sclerosis Versus Neuromyelitis Optica Spectrum Disorder","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":100,"lead_sponsor_name":"Assiut University","has_results":false},{"nct_id":"NCT02073279","title":"Efficacy and Safety Study of Satralizumab (SA237) as Monotherapy to Treat Participants With Neuromyelitis Optica (NMO) and Neuromyelitis Optica Spectrum Disorder (NMOSD)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":95,"lead_sponsor_name":"Hoffmann-La Roche","has_results":true},{"nct_id":"NCT02028884","title":"Efficacy and Safety Study of Satralizumab (SA237) as Add-on Therapy to Treat Participants With Neuromyelitis Optica (NMO) and NMO Spectrum Disorder (NMOSD)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":85,"lead_sponsor_name":"Hoffmann-La Roche","has_results":true},{"nct_id":"NCT06312644","title":"Study of Ultomiris® (Ravulizumab) Safety in Pregnancy","phase":"","overall_status":"RECRUITING","enrollment_count":75,"lead_sponsor_name":"Alexion Pharmaceuticals, Inc.","has_results":false},{"nct_id":"NCT06903130","title":"Clinical Study to Evaluate the Effects of the Complement C5 Inhibitor Ravulizumab on Serum Neurofilament Light Chain (sNfL) and Glial Fibrillary Acidic Protein (sGFAP) Levels in Patients With Aquaporin-4-Positive (AQP4-Ab+) Neuromyelitis Optica Spectrum Disorder (NMOSD)","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":40,"lead_sponsor_name":"National and Kapodistrian University of Athens","has_results":false},{"nct_id":"NCT07182409","title":"Efficacy and Safety of Monoclonal Antibody in Acute Phase of Neuromyelitis Optica Spectrum Disorder","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":40,"lead_sponsor_name":"First Affiliated Hospital of Chongqing Medical University","has_results":false},{"nct_id":"NCT06869278","title":"A Study of LCAR-AIO CAR-T Cells for Treating Relapsed/Refractory Neurological Autoimmune Diseases","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":37,"lead_sponsor_name":"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology","has_results":false},{"nct_id":"NCT06906692","title":"Meningococcal Vaccination in Patients on Complement Inhibitors","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":35,"lead_sponsor_name":"Fondazione Policlinico Universitario Agostino Gemelli IRCCS","has_results":false},{"nct_id":"NCT06724809","title":"Efficacy, Safety, PK, PD, and ADA of Eculizumab in Chinese Adults With NMOSD","phase":"PHASE3","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":21,"lead_sponsor_name":"Alexion Pharmaceuticals, Inc.","has_results":false},{"nct_id":"NCT06775912","title":"Clinical Study on Targeted CD19/BCMA CAR-T Therapy for Autoimmune Diseases","phase":"EARLY_PHASE1","overall_status":"RECRUITING","enrollment_count":18,"lead_sponsor_name":"Nanjing Bioheng Biotech Co., Ltd.","has_results":false},{"nct_id":"NCT06888622","title":"BLAZE-Limiting Approach in NMOSD","phase":"","overall_status":"COMPLETED","enrollment_count":9,"lead_sponsor_name":"Huashan Hospital","has_results":false},{"nct_id":"NCT05199688","title":"A Study To Evaluate Pharmacokinetics, Efficacy, Safety, Tolerability, And Pharmacodynamics Of Satralizumab In Pediatric Patients With Aquaporin-4 Antibody Positive Neuromyelitis Optica Spectrum Disorder (NMOSD)","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":8,"lead_sponsor_name":"Hoffmann-La Roche","has_results":false},{"nct_id":"NCT07526493","title":"Safety and Pharmacodynamics of QH103 Cell Injection in the Treatment of Patients With Relapsed/Refractory Antibody-Mediated Neurological Autoimmune Diseases.","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":6,"lead_sponsor_name":"Tongji Hospital","has_results":false},{"nct_id":"NCT05269667","title":"A Study In Neuromyelitis Optica Spectrum Disorder (NMOSD) With Satralizumab As An Intervention","phase":"PHASE4","overall_status":"TERMINATED","enrollment_count":4,"lead_sponsor_name":"Hoffmann-La Roche","has_results":true}],"total":23},"guidelines":[],"source":"Drug Landscape verified database"}